Skip to main content
Fig. 2 | Antimicrobial Resistance & Infection Control

Fig. 2

From: Real-world use of ceftolozane/tazobactam: a systematic literature review

Fig. 2

Infections of patients treated with C/T by publication year*. *Excluding patients for which infection was not specified. **Other includes genital infection, CNS infection, liver abscess, mediastinitis, device-related infections, vascular infection, and otitis and mastoiditis. CNS: Central nervous system; C/T: Ceftolozane/tazobactam; IAI: Intra-abdominal infection; RTI: Respiratory tract infection; SSTI: Skin and soft tissue infection; UTI: Urinary tract infection

Back to article page